Etanercept-Methotrexate Combination Therapy Compared with Etanercept Monotherapy in Rheumatoid Arthritis Patients with Moderate or Severe Disease in the CAMEO Trial

被引：0
|
作者：
Keystone, Edward [1 ]
Haraoui, Boulos [2 ]
Thorne, Carter [3 ]
Poulin-Costello, Melanie [4 ]
Trottier, Eric [4 ]
Vieira, Andrew
Pope, Janet [5 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Univ Montreal, Montreal, PQ, Canada
[3] Southlake Reg Hlth Ctr, Arthrit Program, Newmarket, Suffolk, England
[4] Amgen Canada Inc, Mississauga, ON, Canada
[5] Univ Western Ontario, London, ON N6A 3K7, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
122
引用
收藏
页码：1507 / 1507
页数：1
相关论文
共 50 条
  • [21] Clinical and Radiographic Outcomes With Etanercept and Etanercept and Methotrexate In Patients With Rheumatoid Arthritis: Two-Year Results From The Canadian Methotrexate and Etanercept Outcome Study (CAMEO)
    Haraoui, Boulos
    Thorne, J. Carter
    Keystone, Edward C.
    Poulin-Costello, Melanie
    Trottier, Eric
    Vieira, Andrew
    Pope, Janet E.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S622 - S622
  • [22] One-Year Results from the Canadian Methotrexate and Etanercept Outcome (CAMEO) Study: A Randomized Trial of Etanercept and Methotrexate versus Etanercept Alone in Active Rheumatoid Arthritis
    Pope, Janet
    Haraoui, Boulos
    Thorne, Carter
    Poulin-Costello, Melanie
    Vieira, Andrew
    Keystone, Edward
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 998 - 999
  • [23] Etanercept marketed for moderate, severe rheumatoid arthritis
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (24) : 2593 - 2593
  • [24] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN A RANDOMIZED CONTROLLED TRIAL IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS PATIENTS
    Bird, P.
    Wollenhaup, J.
    Lee, S. -H.
    Szekanecz, Z.
    Neira, O.
    Hammond, C.
    Vlahos, B.
    Szumski, A.
    Koenig, A. S.
    Kotak, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 633 - 633
  • [25] The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy
    van der Heijde, D.
    Burmester, G.
    Melo-Gomes, J.
    Codreanu, C.
    Mola, E. Martin
    Pedersen, R.
    Freundlich, B.
    Chang, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 182 - 188
  • [26] ACHIEVEMENT AND MAINTENANCE OF REMISSION/LOW DISEASE ACTIVITY OVER 24 MONTHS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ETANERCEPT OR ETANERCEPT plus METHOTREXATE IN THE CANADIAN METHOTREXATE AND ETANERCEPT OUTCOME (CAMEO) STUDY
    Pope, J. E.
    Haraoui, B.
    Thorne, J. C.
    Phan-Chronis, K.
    Poulin-Costello, M.
    Vieira, A.
    Keystone, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 240 - 240
  • [27] Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
    Josef S. Smolen
    Annette Szumski
    Andrew S. Koenig
    Thomas V. Jones
    Lisa Marshall
    Arthritis Research & Therapy, 20
  • [28] Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
    Smolen, Josef S.
    Szumski, Annette
    Koenig, Andrew S.
    Jones, Thomas V.
    Marshall, Lisa
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [29] Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
    Smolen, Josef S.
    Nash, Peter
    Durez, Patrick
    Hall, Stephen
    Ilivanova, Elena
    Irazoque-Palazuelos, Fedra
    Miranda, Pedro
    Park, Min-Chan
    Pavelka, Karel
    Pedersen, Ronald
    Szumski, Annette
    Hammond, Constance
    Koenig, Andrew S.
    Vlahos, Bonnie
    LANCET, 2013, 381 (9870): : 918 - 929
  • [30] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON DISEASE ACTIVITY IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS: INTERIM OVERALL AND AUSTRALIAN RESULTS FROM THE PRESERVE TRIAL
    Nash, P.
    Hall, S.
    Will, R.
    Smith, M.
    Buchanan, R.
    Smolen, J.
    Thirunavukkarasu, K.
    Marshall, L.
    Hammond, C.
    Vlahos, B.
    Pedersen, R.
    Koenig, A.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 20 - 20
12345